News
Weight loss medications and bariatric surgery used to be considered last-resort options, but now, they’re everywhere. More ...
AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company ...
21h
NewsNation on MSNOzempic, Wegovy could reverse severe liver disease, study suggestsDrugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The international study led by a Virginia Commonwealth University researcher ...
NAUSEA, constipation, breathing problems, racing heart… the list of Ozempic side effects appears to be growing by the day.
Decades of studies and statistics have shown that women are consistently held back in the workplace because of their gender.
The $560 million company will sack staff and stop selling products at Woolworths and Priceline and concentrate on selling ...
The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...
Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...
Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...
3d
Best Life on MSNOzempic and Wegovy May Have Landed 25,000 People in the ER—Here's the Scary Reason WhyOf the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results